Approval · Notice of Compliance 21133 · 2018
BRINAVESS: Notice of Compliance 21133
Issued July 24, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21133
- Date
- July 24, 2018
- Company
- Cipher Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BRINAVESS | 02462400 | Marketed |
Medicinal ingredients
- VERNAKALANT HYDROCHLORIDE 20 MG per ML